Decorative: Menu Icon

Christopher B. Eckman, PhD

Professor of Biomedical Sciences


Professor of Biomedical Sciences

Dr. Eckman is a founder and managing director of BRInj, where he also serves as a Professor of Biomedical Sciences. Prior to joining BRInj, Dr. Eckman served as Professor and Chair of the Department of Neuroscience at the Mayo Clinic College of Medicine, where he directed the Laboratory of Neurodegenerative Disease Therapeutics. Professor Eckman has focused much of his scientific career on furthering our understanding of complex diseases such as Alzheimer’s, and Parkinson’s and on lysosomal storage disorders such as Globoid Cell Leukodystrophy (Krabbe disease). Dr. Eckman has published over 95 manuscripts resulting from his work, many in the world’s leading journals such as Science, Nature, Nature Medicine, Neuron, The Journal of Neuroscience, The Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences. In addition to his work in pediatric metabolic diseases, Dr. Eckman has been consistently named one of the top 100 most-cited researchers in Alzheimer’s disease research in the world. He is a member of the editorial boards of the International Journal of Clinical and Experimental Pathology and the Journal of Current Alzheimer’s Research. He has been a chartered member of multiple NIH study sections and regularly consults for multiple journals other government agencies and foundations. Dr. Eckman is a member of the American Society for Biochemistry and Molecular Biology and sits on the Scientific Advisory Board of the Institute for the Study of Aging in Manhattan.

Recently, Dr. Eckman has focused his attention toward the development of novel therapeutic agents in many of these same conditions, capitalizing on the vast amount of mechanistic information available. Current projects, in partnership with Dr. Aimee Herdt, are to develop nanoparticle based delivery methods for second generation enzyme replacement therapies, and in partnership with Drs Pacheco-Quinto, Ladino and Peng, to develop novel therapies for Alzheimer’s disease and stroke.


PhD, Neuroscience, Case Western Reserve University
BA, Child Development and Zoology, Connecticut College


View on >


Department Chair, Mayo Clinic College of Medicine, Neuroscience
Professor, Mayo Clinic College of Medicine, Neuroscience
Postdoctoral Training, Mayo Clinic College of Medicine, Neuroscience